Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacological approaches for targeting cystic fibrosis nonsense mutations

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112436Source: DataRank Database

Pharmacological approaches for targeting cystic fibrosis nonsense mutations is a research paper published in European Journal of Medicinal Chemistry (2020). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.19)OA: greenTopics (74)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Kim M. Keeling ORCID,Steven M. Rowe ORCID,Jyoti Sharma ORCID

Live enrichment

PubMed:32512483 PMC:PMC7384597 OpenAlex:https://openalex.org/W3026736081

National Institutes of Health

Grant: R35 HL135816

NIDDK NIH HHS

Grant: P30 DK072482

Cystic Fibrosis Foundation

Grant: ROWE19R0

National Institutes of Health

Grant: 5R35HL135816-04

Translational Program in CFTR-Related Airway Diseases

National Institutes of Health

Grant: 3P30DK072482-03S3

UAB CF Research and Translation Core Center

FWCI

3.19

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7384597

publisherhttps://api.elsevier.com/content/article/PII:S0223523420304074?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0223523420304074?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejmech.2020.112436

Fields of Study

Cystic Fibrosis Research AdvancesAdvanced biosensing and bioanalysis techniquesNeonatal Respiratory Health Research0301 basic medicine0303 health sciences03 medical and health sciencesAminophenolsAminopyridinesAnimalsBenzodioxolesCodon, NonsenseCystic FibrosisDose-Response Relationship, DrugHumansIndolesMolecular StructureMutationPyrazolesPyridinesPyrrolidinesQuinolonesStructure-Activity Relationship

MeSH Terms

AminophenolsAminopyridinesAnimalsCystic FibrosisDose-Response Relationship, DrugHumansIndolesMutationPyrazolesPyridinesPyrrolidinesStructure-Activity RelationshipQuinolonesMolecular StructureCodon, NonsenseBenzodioxoles

Keywords

IvacaftorPotentiatorCystic fibrosisNonsenseCystic fibrosis transmembrane conductance regulatorNonsense mutationMutationNephronophthisisComputational biologyBioinformaticsGeneticsChemistryMedicineGenePharmacologyBiologyPhenotypeMissense mutationCombination therapyCftrNonsense MutationsTranslational ReadthroughIndolesPyrrolidinesDose-Response Relationship, DrugMolecular StructurePyridinesAminopyridinesQuinolonesAminophenolsStructure-Activity RelationshipCodon, NonsenseAnimalsHumansPyrazolesBenzodioxoles

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Pharmacological approaches for targeting cystic fibrosis nonsense mutations

FAIR Checklist

Authors (3)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)